Products Categories
| CAS No.: | 16676-29-2 |
|---|---|
| Name: | Naltrexone hydrochloride |
| Article Data: | 5 |
| Molecular Structure: | |
|
|
|
| Formula: | C20H23NO4.HCl |
| Molecular Weight: | 377.868 |
| Synonyms: | Morphinan-6-one,17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, hydrochloride, (5a)- (9CI);Antaxone;Depade;EN 1639A;NIH 8503;Nalorex;Trexan; |
| EINECS: | 240-723-0 |
| Density: | 1.47 g/cm3 |
| Melting Point: | 274-276 °C |
| Boiling Point: | 558.1 °C at 760 mmHg |
| Flash Point: | 291.4 °C |
| Solubility: | water: 50 mg/mL, clear, colorless |
| Appearance: | white crystalline powder |
| Hazard Symbols: |
 Xn
|
| Risk Codes: | 22 |
| Safety: | 22-36 |
| PSA: | 70.00000 |
| LogP: | 2.26530 |
- 483366-12-7(2S,4R)-1-Boc-2-cyano-4-hydroxypyrrolidine
- 173606-50-3BOC-10-AMINODECANOIC ACID
- 361456-36-2METHYL (R)-(+)-ISOCYANATO-3-PHENYLPROPI&
- 5156-58-1N-(1-Benzyl-4-pipperidinyl)-N-phenylpropanamide HCl
- 81281-59-67-Benzylideneaminotheophylline
- 50288-62-5threo-Phenyl-2-piperidyl acetamide
- 82993-81-5D-threo-Ritalinic acid hydrochloride
- 47087-37-6Z-D-Glu-OMe
- 73441-42-6METHYL-5-CHLORO-2,2-DIMETHYLVALERATE
- 211914-50-0N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride
- 2398-96-1Tolnaftate
- 563-47-33-Chloro-2-methylpropene
- 1948-33-0tert-Butylhydroquinone
- 103-83-3N,N-Dimethylbenzylamine
- 9001-75-6Pepsin
- 1777-82-8Benzenemethanol,2,4-dichloro-
- 83881-51-0Cetirizine
- 1762-95-4Ammonium thiocyanate
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
What can I do for you?
Get Best Price
Specification
The Naltrexone hydrochloride is an organic compound with the formula C20H23NO4.HCl. The systematic name of this chemical is (5α)-17-(cyclopropylmethyl)-3,14-dihydroxy-4,5-epoxymorphinan-6-one hydrochloride. With the CAS registry number 16676-29-2, it is also named as morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, (5α)-, hydrochloride. The product's categories are Intermediates & Fine Chemicals; Pharmaceuticals; Antagonists; Opioids; Pharmacologicals; Enzyme Inhibitors; Enzyme Inhibitors by Type; Other; Opioid receptor and Opioid-like receptor. Besides, it is fine chemical, and can be used as nonselective opioid receptor antagonist, intermediate and congener of naloxone. The main use of naltrexone is for the treatment of alcohol dependence.
Physical properties about Naltrexone hydrochloride are: (1)ACD/LogP: 1.80; (2)ACD/LogD (pH 5.5): -0.3; (3)ACD/LogD (pH 7.4): 1.35; (4)ACD/BCF (pH 5.5): 1; (5)ACD/BCF (pH 7.4): 4.9; (6)ACD/KOC (pH 5.5): 1.82; (7)ACD/KOC (pH 7.4): 81.08; (8)#H bond acceptors: 5; (9)#H bond donors: 2; (10)#Freely Rotating Bonds: 4; (11)Polar Surface Area: 48 Å2; (12)Flash Point: 291.4 °C; (13)Enthalpy of Vaporization: 88.4 kJ/mol; (14)Boiling Point: 558.1 °C at 760 mmHg; (15)Vapour Pressure: 2.71E-13 mmHg at 25°C.
When you are using this chemical, please be cautious about it as the following:
It is harmful if swallowed. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. Besides, this chemical is irritating to eyes, respiratory system and skin. When you are using it, do not breathe dust.
You can still convert the following datas into molecular structure:
(1)SMILES: Cl.O=C4[C@@H]5Oc1c2c(ccc1O)C[C@H]3N(CC[C@]25[C@@]3(O)CC4)CC6CC6
(2)InChI: InChI=1/C20H23NO4.ClH/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11;/h3-4,11,15,18,22,24H,1-2,5-10H2;1H/t15-,18+,19+,20-;/m1./s1
(3)InChIKey: RHBRMCOKKKZVRY-ITLPAZOVBS
(4)Std. InChI: InChI=1S/C20H23NO4.ClH/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11;/h3-4,11,15,18,22,24H,1-2,5-10H2;1H/t15-,18+,19+,20-;/m1./s1
(5)Std. InChIKey: RHBRMCOKKKZVRY-ITLPAZOVSA-N
The toxicity data is as follows:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| guinea pig | LD50 | oral | 1490mg/kg (1490mg/kg) | Medicamentos de Actualidad. Vol. 21, Pg. 264, 1985. | |
| monkey | LD50 | oral | 3gm/kg (3000mg/kg) | Medicamentos de Actualidad. Vol. 21, Pg. 264, 1985. | |
| mouse | LD50 | oral | 1100mg/kg (1100mg/kg) | Medicamentos de Actualidad. Vol. 21, Pg. 264, 1985. | |
| rat | LD50 | oral | 1450mg/kg (1450mg/kg) | Medicamentos de Actualidad. Vol. 21, Pg. 264, 1985. |